Leukopenia as a Possible Biomarker for Overall Survival in Glioblastoma Patients Treated with Temozolomide

被引：0
|
作者：
Ho, Ka-wai G. [1 ]
Wong, Eric T. [1 ]
Uhlmann, Erik J. [1 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Neurol, Boston, MA USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.167
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Leukopenia is a biomarker for effective temozolomide dosing and predicts overall survival of patients with glioblastoma
    Ho, K. Grace
    Uhlmann, Erik N.
    Wong, Eric T.
    Uhlmann, Erik J.
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 13 (06) : 1 - 6
  • [2] Actual body weight dosing of temozolomide and overall survival in patients with glioblastoma
    Hsu, Phoebe
    Folkman, Frances
    Ghosh, Sunita
    de Robles, Paula
    Leckie, Catriona
    Dersch-Mills, Deonne
    Coppens, Roland
    Chambers, Carole
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1723 - 1729
  • [3] Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
    Minh Thi Tieu
    Leif E. Lovblom
    Mairéad G. McNamara
    Warren Mason
    Normand Laperriere
    Barbara-Ann Millar
    Cynthia Ménard
    Tim-Rasmus Kiehl
    Bruce A. Perkins
    Caroline Chung
    Journal of Neuro-Oncology, 2015, 124 : 119 - 126
  • [4] GLYCEMIA IMPACTS SURVIVAL OF GLIOBLASTOMA PATIENTS TREATED WITH RADIATION AND TEMOZOLOMIDE
    Tieu, Mimi
    Lovblom, Erik
    Macnamara, Mairead
    Mason, Warren
    Rodin, Danielle
    Tai, Elizabeth
    Ubhi, Kuldesh
    Laperriere, Normand
    Millar, Barbara-Ann
    Menard, Cynthia
    Perkins, Bruce
    Chung, Caroline
    NEURO-ONCOLOGY, 2013, 15 : 76 - 76
  • [5] Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
    Minh Thi Tieu
    Lovblom, Leif E.
    McNamara, Mairead G.
    Mason, Warren
    Laperriere, Normand
    Millar, Barbara-Ann
    Menard, Cynthia
    Kiehl, Tim-Rasmus
    Perkins, Bruce A.
    Chung, Caroline
    JOURNAL OF NEURO-ONCOLOGY, 2015, 124 (01) : 119 - 126
  • [6] Improved Overall Survival in CNS Lymphoma Patients Treated with Concurrent Temozolomide and Radiation
    Laucis, A. M.
    Selwa, K.
    Lawrence, T. S.
    Junck, L.
    Cuneo, K. C.
    Kim, M. M.
    Wahl, D. R.
    Umemura, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S243 - S244
  • [7] Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide
    Quan, Rencui
    Zhang, Huaqing
    Li, Zihuang
    Li, Xianming
    MEDICINE, 2020, 99 (02)
  • [8] Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
    Roh, Tae Hoon
    Moon, Ju Hyung
    Park, Hun Ho
    Kim, Eui Hyun
    Hong, Chang-Ki
    Kim, Se Hoon
    Kang, Seok-Gu
    Chang, Jong Hee
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [9] Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
    Tae Hoon Roh
    Ju Hyung Moon
    Hun Ho Park
    Eui Hyun Kim
    Chang-Ki Hong
    Se Hoon Kim
    Seok-Gu Kang
    Jong Hee Chang
    Scientific Reports, 10
  • [10] Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide
    Brawanski, Konstantin R.
    Sprung, Susanne
    Freyschlag, Christian F.
    Hoeftberger, Romana
    Stroebel, Thomas
    Haybaeck, Johannes
    Thome, Claudius
    Manzl, Claudia
    Birkl-Toeglhofer, Anna M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
12345